Pearson PLC
24 January 2008
24 January 2008
PEARSON'S ACQUISITION OF HARCOURT ASSESSMENT CLEARED BY U.S. JUSTICE DEPARTMENT
Pearson, the international education and information company, today announces
that its purchase of the Harcourt Assessment business from Reed Elsevier has
received clearance from the U.S. Department of Justice. The transaction is
expected to be completed on 28 January 2008.
As a condition for approval, Pearson will divest up to three diagnostic
assessment tests and one further test in development.
Pearson announced on 4 May 2007 that it had agreed to acquire Harcourt
Assessment and Harcourt Education International from Reed Elsevier for $950
million in cash. The transaction extends Pearson's position as the world's
leading education company by adding new capabilities, complementary products and
international reach. The acquisition of Harcourt's international education
business was completed in 2007.
ENDS
For more information:
Luke Swanson/ Simon Mays-Smith/ Charles Goldsmith +44 (0)20 7010 2310
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.